{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:13:52Z","timestamp":1768317232302,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068632 (IMPAACT LOC)"],"award-info":[{"award-number":["UM1AI068632 (IMPAACT LOC)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/jpids\/pix050","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T11:07:25Z","timestamp":1496488045000},"page":"e109-e115","source":"Crossref","is-referenced-by-count":15,"title":["Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy"],"prefix":"10.1093","volume":"6","author":[{"given":"Ann J","family":"Melvin","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Disease, Department of Pediatrics, University of Washington and Seattle Children\u2019s Research Institute;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Warshaw","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Compagnucci","sequence":"additional","affiliation":[{"name":"INSERM, SC10-US19, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yacine","family":"Saidi","sequence":"additional","affiliation":[{"name":"INSERM, SC10-US19, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Harrison","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Turkova","sequence":"additional","affiliation":[{"name":"Medical Research Council, Clinical Trials Unit, London, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Tudor-Williams","sequence":"additional","affiliation":[{"name":"Imperial College London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and the PENPACT-1 (PENTA 9\/PACTG 390\/ANRS 103) Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"key\n\t\t\t\t20180328140230_CIT0001","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa1113249","article-title":"Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children","volume":"366","author":"Violari","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0002","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0003","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180328140230_CIT0004","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/jiq071","article-title":"T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women","volume":"203","author":"Kaplan","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/infdis\/jiq084","article-title":"Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care","volume":"203","author":"Triant","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0006","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MCA.0b013e3282f6dffb","article-title":"Subclinical atherosclerosis and cardiovascular risk factors in HIV-infected children: PERI study","volume":"19","author":"Giuliano","year":"2008","journal-title":"Coron Artery Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0007","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/QAD.0b013e328133f29c","article-title":"Increased carotid intima media thickness and cardiac biomarkers in HIV infected children","volume":"21","author":"McComsey","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328140230_CIT0008","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00002030-200109280-00011","article-title":"Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy","volume":"15","author":"Mora","year":"2001","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328140230_CIT0009","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00467-015-3260-x","article-title":"Renal abnormalities in a cohort of HIV-infected children and adolescents","volume":"31","author":"Le\u00e3o","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180328140230_CIT0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(10)70313-3","article-title":"First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2\/3 trial","volume":"11","author":"Babiker","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0011","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316771","volume-title":"Statistical Intervals: A Guide for Practitioners","author":"Hahn","year":"1991"},{"key":"key\n\t\t\t\t20180328140230_CIT0012","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1097-0258(19980228)17:4<407::AID-SIM742>3.0.CO;2-L","article-title":"British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood","volume":"17","author":"Cole","year":"1998","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0013","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0014","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1473-3099(12)70242-6","article-title":"Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial","volume":"12","author":"Puthanakit","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/hiv.12399","article-title":"Paediatric European Network for Treatment of AIDS treatment guideline 2016 update: antiretroviral therapy recommended for all children living with HIV","volume":"18","author":"Foster","year":"2017","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0016","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180328140230_CIT0017","volume-title":"Guidelines for the use of antiretroviral agents in pediatric HIV infection","author":"Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children"},{"key":"key\n\t\t\t\t20180328140230_CIT0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00006454-199801000-00005","article-title":"Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients","volume":"17","author":"Valentine","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180328140230_CIT0019","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(03)14793-9","article-title":"Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis","volume":"362","author":"Dunn","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328140230_CIT0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1758-2652-13-31","article-title":"Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children","volume":"13","author":"Buck","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180328140230_CIT0021","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ijid.2007.10.008","article-title":"Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children","volume":"12","author":"Lapphra","year":"2008","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0022","doi-asserted-by":"crossref","first-page":"e111948","DOI":"10.1371\/journal.pone.0111948","article-title":"Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study","volume":"9","author":"Mutwa","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140230_CIT0023","doi-asserted-by":"crossref","first-page":"19467","DOI":"10.7448\/IAS.18.1.19467","article-title":"PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-na\u00efve and -experienced infants and children aged \u22653 months to <6 years","volume":"18","author":"Strehlau","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180328140230_CIT0024","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/QAI.0b013e3182423668","article-title":"Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda","volume":"59","author":"Tukei","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328140230_CIT0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/INF.0b013e3182a01dfb","article-title":"Prevalence and predictors of elevated aspartate aminotransferase-to-platelet ratio index in Latin American perinatally HIV-infected children","volume":"33","author":"Siberry","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180328140230_CIT0026","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0025-7125(05)70526-5","article-title":"Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"81","author":"Coyle","year":"1997","journal-title":"Med Clin North Am"},{"key":"key\n\t\t\t\t20180328140230_CIT0027","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00043426-199024000-00008","article-title":"Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor","volume":"12","author":"Ellaurie","year":"1990","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t20180328140230_CIT0028","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1093\/infdis\/jis195","article-title":"HIV infection and coronary heart disease: an intersection of epidemics","volume":"205","author":"Triant","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0029","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/605578","article-title":"Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy","volume":"49","author":"Ross","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11904-011-0081-9","article-title":"Cardiovascular complications in children with HIV infection","volume":"8","author":"Sims","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t20180328140230_CIT0031","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/jac\/dkv036","article-title":"Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity","volume":"70","author":"Bastard","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328140230_CIT0032","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/QAD.0b013e328354f4fb","article-title":"Inflammation markers after randomization to abacavir\/lamivudine or tenofovir\/emtricitabine with efavirenz or atazanavir\/ritonavir","volume":"26","author":"McComsey","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328140230_CIT0033","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0034","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0036","doi-asserted-by":"crossref","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140230_CIT0037","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","article-title":"Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection","volume":"56","author":"Baker","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328140230_CIT0038","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0039","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/QAI.0b013e3181e222c9","article-title":"Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1","volume":"55","author":"Miller","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328140230_CIT0041","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/INF.0b013e3181ed9f4c","article-title":"Associations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapy","volume":"29","author":"Cervia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180328140230_CIT0042","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/QAI.0b013e31825b03be","article-title":"Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment","volume":"60","author":"Kaplan","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328140230_CIT0043","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2334-14-122","article-title":"Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study","volume":"14","author":"Hattab","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180328140230_CIT0044","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2008.02.003","article-title":"High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection","volume":"201","author":"Guimar\u00e3es","year":"2008","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180328140230_CIT0045","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/QAD.0000000000000375","article-title":"Microbial translocation and T cell activation are not associated in chronic HIV-infected children","volume":"28","author":"Madrid","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328140230_CIT0046","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamapediatrics.2014.1560","article-title":"Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents","volume":"168","author":"Persaud","year":"2014","journal-title":"JAMA Pediatr"},{"key":"key\n\t\t\t\t20180328140230_CIT0047","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/QAD.0b013e328337b9a0","article-title":"HIV is associated with thrombophilia and high D-dimer in children and adolescents","volume":"24","author":"Pontrelli","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328140230_CIT0048","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-1293.2011.00970.x","article-title":"Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children","volume":"13","author":"Miller","year":"2012","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328140230_CIT0049","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/aid.2010.0154","article-title":"Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals","volume":"27","author":"Shikuma","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328140230_CIT0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/jiv123","article-title":"Factors associated with plasma IL-6 levels during HIV infection","volume":"212","author":"Borges","year":"2015","journal-title":"J Infect Dis"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/6\/3\/e109\/24365126\/pix050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T03:56:04Z","timestamp":1659066964000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/6\/3\/e109\/3979993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,20]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/pix050","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,7,20]]}}}